Penile implants in low flow priapism
- PMID: 37898653
- DOI: 10.1038/s41443-023-00787-1
Penile implants in low flow priapism
Erratum in
-
Publisher Correction: Penile implants in low flow priapism.Int J Impot Res. 2024 Feb;36(1):100. doi: 10.1038/s41443-023-00799-x. Int J Impot Res. 2024. PMID: 38062241 No abstract available.
Abstract
Priapism is a persistent or prolonged erection, in the absence of sexual stimulation, that fails to subside. Prolonged ischaemic or low flow priapism is defined as a full or partial erection persisting for more than 4 h and unrelated to sexual interest or stimulation, characterised by little or no cavernous blood flow. Low flow priapism leads to progressive corporal fibrosis, which could, in turn, lead to long-lasting erectile dysfunction if left untreated. Penile prosthesis implantation is recognised as a management option in refractory and delayed low flow priapism for restoring erectile function with high patient satisfaction rates. However, the ensuing corporal fibrotic scarring poses a surgical challenge to clinicians, given the higher complication rates in this patient subset. Postoperative patient satisfaction has been closely linked to preoperative expectations and perceived loss of penile length. Therefore, thorough patient counselling concerning the risk and benefits of penile implants should be a priority for all clinicians. Moreover, there is a lack of consensus on the ideal prosthesis choice and procedural timing in refractory low flow priapism. In this review, we will examine the existing literature on penile implants in patients with priapism and discuss the options for managing complications associated with penile prosthesis surgery.
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
References
-
- Salonia A, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioglu A, et al. Sexual and reproductive health EAU Guidelines. European Association of Urology Guidelines on Sexual and Reproductive Health-2022. 2022. https://uroweb.org/guidelines/sexual-and-reproductive-health .
-
- Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476–500. https://doi.org/10.1111/J.1743-6109.2009.01625.X . - DOI - PubMed
-
- Roghmann F, Becker A, Sammon JD, Ouerghi M, Sun M, Sukumar S, et al. Incidence of priapism in emergency departments in the United States. J Urol. 2013;190. https://doi.org/10.1016/j.juro.2013.03.118 .
-
- Kulmala RV, Tamella TL. Effects of priapism lasting 24 h or longer caused by intracavernosal injection of vasoactive drugs. Int J Imp Res. 1995;7:131–6. https://europepmc.org/article/med/7496442 .
-
- Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS. et al. The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA/SMSNA guideline. J Urol. 2022;208:43–52. https://doi.org/10.1097/JU.0000000000002767 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
